The company has developed a lipid additive for intravenous nutrition.

Gali Weinreb (23 April 2008)

Sources inform ''Globes'' that High Tech Lipids Ltd., a graduate of Misgav Technology Center, has signed an memorandum of understanding with a European pharmaceutical company to invest $5 million in the company. The name of the investor was not disclosed.
The proceeds will finance preclinical trials of the company's product, a total parenteral nutrition (TPN), or intravenous nutrition, lipid that enhances quality of care, reduces healthcare costs, and may saves lives. The company claims that its patented lipid for TPN may also mitigate risks associated with infections and other complications associated with current products in the $2.2 billion US TPN market.